Raymond James Financial
IART icon

Raymond James Financial’s Integra LifeSciences IART Stock Holding History

Raymond James Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.93M Buy
274,461
+6,535
+2% +$91.4K ﹤0.01% 2745
2026
Q1 		$2.52M Buy
267,926
+850
+0.3% +$9.33K ﹤0.01% 3168
2025
Q4 		$3.32M Buy
267,076
+48,599
+22% +$646K ﹤0.01% 2846
2025
Q3 		$3.13M Buy
218,477
+171,286
+363% +$2.35M ﹤0.01% 2820
2025
Q2 		$579K Sell
47,191
-506
-1% -$7.35K ﹤0.01% 3926
2025
Q1 		$1.05M Buy
47,697
+6,105
+15% +$144K ﹤0.01% 3453
2024
Q4 		$943K Buy
+41,592
New +$908K ﹤0.01% 3488

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Raymond James Financial's IART Position: Q2 2026 in Review

Raymond James Financial increased its Integra LifeSciences (IART) stake by 2.4% in Q2 2026, buying an estimated $91.4K and bringing the position to 274,461 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2745.

Raymond James Financial first reported a position in IART in Q4 2024 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Raymond James Financial held 274,461 shares of Integra LifeSciences worth $4.93M as of Q2 2026.
  • Raymond James Financial bought 6,535 Integra LifeSciences shares in Q2 2026, an estimated $91.4K.
  • Integra LifeSciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2745 holding.
  • Raymond James Financial first reported a position in Integra LifeSciences in Q4 2024 and has held it in 7 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.